Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
BioCryst Pharmaceuticals Stock Price (Quote) NASDAQ:BCRX
$9.76 ( 7.85% ) Friday, 27th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $7.61 | $10.43 | Friday, 27th May 2022 BCRX stock ended at $9.76. This is 7.85% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.79% from a day low at $9.10 to a day high of $9.90. |
| 90 days | $7.61 | $18.60 | |
| 52 weeks | $7.61 | $19.99 |
Historical BioCryst Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-27 | $9.11 | $9.90 | $9.10 | $9.76 | 2 740 348 |
| 2022-05-26 | $8.81 | $9.29 | $8.71 | $9.05 | 2 618 556 |
| 2022-05-25 | $8.60 | $8.83 | $8.45 | $8.80 | 2 199 140 |
| 2022-05-24 | $8.83 | $8.88 | $8.47 | $8.57 | 2 332 293 |
| 2022-05-23 | $9.14 | $9.22 | $8.79 | $8.90 | 1 814 891 |
| 2022-05-20 | $9.11 | $9.20 | $8.67 | $9.10 | 3 201 045 |
| 2022-05-19 | $8.50 | $9.11 | $8.45 | $9.03 | 3 978 035 |
| 2022-05-18 | $8.68 | $8.91 | $8.33 | $8.52 | 3 225 540 |
| 2022-05-17 | $8.70 | $9.00 | $8.50 | $8.90 | 3 294 445 |
| 2022-05-16 | $8.40 | $8.74 | $8.14 | $8.50 | 4 531 509 |
| 2022-05-13 | $8.16 | $8.68 | $7.99 | $8.39 | 5 858 329 |
| 2022-05-12 | $7.80 | $8.17 | $7.61 | $7.89 | 5 516 184 |
| 2022-05-11 | $8.51 | $8.57 | $7.75 | $7.94 | 5 418 818 |
| 2022-05-10 | $8.70 | $9.11 | $8.43 | $8.60 | 5 847 211 |
| 2022-05-09 | $8.93 | $9.07 | $8.26 | $8.37 | 6 300 875 |
| 2022-05-06 | $9.66 | $9.69 | $8.96 | $9.09 | 5 213 173 |
| 2022-05-05 | $9.72 | $10.43 | $9.60 | $9.78 | 7 282 683 |
| 2022-05-04 | $9.82 | $10.22 | $9.43 | $10.18 | 7 098 193 |
| 2022-05-03 | $9.61 | $9.85 | $9.50 | $9.80 | 5 189 989 |
| 2022-05-02 | $9.21 | $9.65 | $9.18 | $9.60 | 7 299 396 |
| 2022-04-29 | $9.71 | $10.02 | $9.25 | $9.29 | 4 852 821 |
| 2022-04-28 | $10.02 | $10.14 | $9.41 | $9.67 | 5 015 699 |
| 2022-04-27 | $9.50 | $10.08 | $9.50 | $9.95 | 3 899 164 |
| 2022-04-26 | $10.03 | $10.24 | $9.48 | $9.50 | 4 690 934 |
| 2022-04-25 | $9.57 | $10.20 | $9.57 | $10.07 | 3 464 873 |
| 2022-04-22 | $9.75 | $9.90 | $9.58 | $9.68 | 1 543 928 |
| 2022-04-21 | $10.25 | $10.47 | $9.54 | $9.69 | 7 324 000 |
| 2022-04-20 | $10.23 | $10.54 | $10.15 | $10.31 | 4 648 500 |
| 2022-04-19 | $10.58 | $10.75 | $10.17 | $10.22 | 6 118 000 |
| 2022-04-18 | $11.04 | $11.09 | $10.55 | $10.61 | 7 621 100 |
| 2022-04-14 | $12.40 | $12.75 | $11.30 | $11.39 | 7 867 135 |
| 2022-04-13 | $10.98 | $12.79 | $10.97 | $12.57 | 8 899 168 |
| 2022-04-12 | $10.83 | $11.29 | $10.66 | $10.93 | 5 926 398 |
| 2022-04-11 | $10.40 | $11.17 | $10.17 | $10.88 | 10 182 894 |
| 2022-04-08 | $13.97 | $13.99 | $11.02 | $11.12 | 37 202 900 |
| 2022-04-07 | $16.24 | $18.00 | $16.24 | $17.88 | 6 274 600 |
| 2022-04-06 | $16.00 | $16.56 | $15.81 | $16.47 | 2 816 100 |
| 2022-04-05 | $16.50 | $16.73 | $16.05 | $16.23 | 2 848 000 |
| 2022-04-04 | $16.60 | $16.86 | $16.33 | $16.76 | 2 122 200 |
| 2022-04-01 | $16.24 | $17.05 | $16.09 | $16.60 | 2 659 067 |
| 2022-03-31 | $16.46 | $16.56 | $16.25 | $16.26 | 1 607 725 |
| 2022-03-30 | $17.09 | $17.30 | $16.39 | $16.44 | 1 799 878 |
| 2022-03-29 | $16.47 | $17.57 | $16.44 | $17.11 | 3 230 900 |
| 2022-03-28 | $15.91 | $16.42 | $15.74 | $16.21 | 1 665 900 |
| 2022-03-25 | $16.63 | $16.70 | $15.93 | $15.99 | 2 025 000 |
| 2022-03-24 | $16.52 | $16.70 | $16.07 | $16.68 | 1 454 400 |
| 2022-03-23 | $16.67 | $16.90 | $16.39 | $16.41 | 1 583 400 |
| 2022-03-22 | $15.90 | $16.79 | $15.64 | $16.73 | 3 066 546 |
| 2022-03-21 | $16.18 | $16.62 | $15.73 | $15.78 | 3 624 347 |
| 2022-03-18 | $15.74 | $17.12 | $15.61 | $16.22 | 6 937 383 |
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its product candidates include peramivir, an intravenous neuraminidase inhibitor, which is approved for uncomplicated seasonal and acute influenza; BCX4161, an oral serine protease inhibitor, which is in Phase II/III clinical trial for hereditary angioedema (HAE); BCX7353, ... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
